Categories

Clinical utility study in stage I-IV colorectal cancer (CRC) evaluates how adjuvant treatment decisions are impacted by using the Signatera™ MRD test Natera, Inc. (NASDAQ: NTRA) a global leader in cell-free DNA testing, today announced a milestone with over 100 sites initiated and 1,000 patients enrolled across the U.S. in its BESPOKE CRC study, a prospective, […]

Merck would like to inform you that the FDA has approved KEYTRUDA® (pembrolizumab) Injection 100 mg, in combination with chemotherapy, with or without bevacizumab, for the treatment of patients with persistent, recurrent, or metastatic cervical cancer whose tumors express PD-L1 (CPS ≥1) as determined by an FDA-approved test.    •  PD-L1 diagnostic testing is required prior to initiating treatment with […]

Melphalan Flufenamide (PEPAXTO®) is now included in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Multiple Myeloma Version 6.2021 – April 12, 2021 Category 2A1 Definitions for National Comprehensive Cancer Network® (NCCN®) Categories:   Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate.   For more […]

U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.

Patients between 15 and 39 must deal with psychosocial effects of cancer and recovery.

This series of guides offers extensive information on helping children understand and deal with cancer in another family member.

WASHINGTON, D.C. – February 1, 2017 – A new White Paper by the law firm of Frier Levitt, LLC examines the ongoing practice by pharmacy Benefit Managers (PBMs) to increase corporate profits through murky “direct and indirect remuneration” fees (commonly known as “DIR Fees”) charged to community oncology practices, as well as retail and specialty […]

On June 1, 2016, the U. S. Food and Drug Administration approved cobas EGFR Mutation Test v2 (Roche Molecular Systems, Inc.) using plasma specimens as a companion diagnostic test for the detection of exon 19 deletions or exon 21 (L858R) substitution mutations in the epidermal growth factor recptor (EGFR) gene to identify patients with metastatic […]

New Milliman Study Commissioned by Community Oncology Alliance Finds Costs for Treating Patients With Cancer Increased at Essentially Same Rate as Other Health Care Spending

Last year in the United States, more than 136,000 people were diagnosed with—and more than 50,000 died from—colorectal cancer, according to the National Cancer Institute. It is the second leading cause of cancer-related deaths in the United States, striking some groups more often than others. The toll this disease takes on minorities is especially high, […]